Research programme: sulfonamide derivatives - TelikAlternative Names: Carboxylesterase inhibitors
Latest Information Update: 20 Dec 2007
At a glance
- Originator Telik
- Class Sulfonamides
- Mechanism of Action Enzyme inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemoprevention
Most Recent Events
- 20 Apr 2004 Preclinical trials in Cancer (Prevention)/Chemoprevention in USA (unspecified route)